Sfoglia per RIVISTA
HEMATOLOGICAL ONCOLOGY
Collezione AOU Novara

  

Items : 16

Prescription patterns of venetoclax in acute myeloid leukemia. in Hematological oncology / Hematol Oncol. 2024 Jul;42(4):e3298. doi: 10.1002/hon.3298.

2024
AOU Novara

Ucciero A; Traversa G; Pisterna A; Cardinali V; Sciabolacci S; Poloni A; Capelli D; Gaidano G; Patriarca A; Lunghi M;

Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. in Hematological oncology / Hematol Oncol. 2024 Jan;42(1):e3216. doi: 10.1002/hon.3216. Epub 2023 Sep 29.

2024
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Molica S; Iannella E; Malgieri S; Gozzetti A; Gualberti G; Caira M; Finsinger P; Reda G; Coscia M; Vallisa D; Pane F; Cuneo A; Albano F; Zamprogna G; Trentin L; Mauro FR; Albi E; Gaidano G; Laurenti L; Sportoletti P; Chiarenza A;

SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):128-138. doi: 10.1002/hon.3092. Epub 2022 Oct 25.

2023
ASL Torino 5
AO Alessandria
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara

Corradini P; Cilloni D; Visani G; Federici AB; Tisi MC; Cudillo L; Galimberti S; Gherlinzoni F; Visco C; Bertù L; Pagano L; Guidetti A; Coviello E; Passamonti F; Bocchia M; Gentile M; Della Porta MG; Mohamed S; Mauro FR; Gambacorti-Passerini C; Massaia M; Billio A; Scattolin A; Marchesi F; Fracchiolla NS; Cattaneo C; Derenzini E; Arcaini L; Trentin L; et alii...

Role of chemotherapy in the treatment of chronic lymphocytic leukemia in the era of targeted therapies in Italy. A Campus CLL network report. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):201-204. doi: 10.1002/hon.3047. Epub 2022 Aug 19.

2023
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU Novara

Marasca R; Foà R; Ballotta L; Moia R; Cuneo A; Chiurazzi F; Reda G; Gottardi D; Orsucci L; Maccaferri M; De Paoli L;

The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):78-87. doi: 10.1002/hon.3081. Epub 2022 Oct 7.

2023
AO Alessandria
AOU Città della Salute di Torino
AOU Novara

Merli F; Bocchia M; Spina M; Marcheselli L; Mammi C; Daffini R; Nassi L; Tani M; Musurca G; Cavallo F; Al Essa W; Gini G; Sartori R; Merli M; Tafuri A; Zanni M; Botto B; Arcari A; Petrucci L; Zilioli VR; Balzarotti M; Marino D; Luminari S; Usai SV; Pennese E; Hohaus S; Fabbri A; Puccini B; Tucci A; et alii...

Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study. in Hematological oncology / Hematol Oncol. 2023 Dec;41(5):877-883. doi: 10.1002/hon.3199. Epub 2023 Jul 1.

2023
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Laurenti L; Cuneo A; Foà R; Trentin L; Coscia M; Rigolin GM; Gattei V; Mattiello V; Sportoletti P; Gentile M; Scortechini I; Moia R; Catania G; Loseto G; Chiurazzi F; Malerba L; De Paolis MR; Angeletti I; Ferrari A; Giordano A; Baratè C; Leone MMA; Quaresmini G; Farina L; Fresa A; Piciocchi A; Vitale C; Reda G; Visentin A; et alii...

Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):567-570. doi: 10.1002/hon.3080. Epub 2022 Oct 10.

2023
AOU Novara

Moia R; Dondolin R; De Propris MS; Talotta D; Mouhssine S; Perutelli F; Reda G; Mattiello V; Rigolin GM; Motta M; Olivieri J; Fanin R; Perbellini O; Ferrarini I; Mauro FR; Del Giudice I; Laurenti L; Tomasso A; Gentile M; Frustaci AM; Tedeschi A; Gozzetti A; Stelitano C; Visco C; Moreno C; Forconi F; Marasca R; Coscia M; Rossi D; et alii...

Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):335-342. doi: 10.1002/hon.3118. Epub 2022 Dec 27.

2023
AO Ordine Mauriziano
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara

Tarella C; Avvedimento EV; Pileri S; Gottardi D; Cignetti A; Risso A; Bruna R; Gueli A; Derenzini E;

Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):953-961. doi: 10.1002/hon.3074. Epub 2022 Sep 15.

2022
AO Alessandria
AOU Novara

Nassi L; Stepanishyna Y; Federico M; Inghirami G; Re A; Rigacci L; Carson KR; Ferreri AJM; Luminari S; De Souza CA; Nagler A; Montoto S; Horwitz SM; Cabrera ME; Pileri SA; Zing NPC; Manni M; Miranda E; Fischer T; Chiattone C; Civallero M;

Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report. in Hematological oncology / Hematol Oncol. 2021 Oct;39(4):570-574. doi: 10.1002/hon.2899. Epub 2021 Jul 13.

2021
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
AO Alessandria
AOU Novara

Foà R; Orsucci L; Penna G; Chiarenza A; Gattei V; Gottardi D; Derenzini E; Levato L; Gozzetti A; Olivieri J; Murru R; Sanna A; Gentile M; Baratè C; Leone M; Stefoni V; Tisi MC; Malerba L; Ibatici A; Marasca R; Chiurazzi F; Varettoni M; Del Poeta G; Marchetti M; Farina L; Giordano A; Re F; De Paoli L; Foglietta M; et alii...

IRF4 L116R mutation promotes proliferation of chronic lymphocytic leukemia B cells inducing MYC. in Hematological oncology / Hematol Oncol. 2021 Dec;39(5):707-711. doi: 10.1002/hon.2915. Epub 2021 Aug 25.

2021
AOU Novara

Benatti S; Atene CG; Fiorcari S; Mesini N; Martinelli S; Zucchini P; Bacchelli F; Maccaferri M; Debbia G; Potenza L; Rossi D; Vallisa D; Trentin L; Gaidano G; Luppi M; Marasca R; Maffei R;

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):326-335. doi: 10.1002/hon.2861. Epub 2021 Mar 26.

2021
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Montillo M; Foà R; Cuneo A; Gentile M; Crea E; Marasca R; Marchetti M; Vignetti M; Mauro FR; Laurenti L; Quaglia FM; Pietrasanta D; Molinari AL; Sportoletti P; Paolini R; Varettoni M; Gaidano G; Murru R; Vitagliano O; Coscia M; Farina L; Cibien F; Zamprogna G; Reda G; Arena V; Visentin A; Piciocchi A; Cavazzini F; Rigolin GM; et alii...

Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity. in Hematological oncology / Hematol Oncol. 2020 Oct;38(4):478-486. doi: 10.1002/hon.2764. Epub 2020 Jul 9.

2020
AOU Città della Salute di Torino
AOU Novara

Zinzani PL; Santoro A; Mamusa AM; Cox C; Scalzulli R; Margiotta-Casaluci G; Bolis S; Spina M; Merli F; Luminari S; Broggi S; Pozzi S; Vitolo U; Angrilli F; Bonifacio E; Pregnolato F; Kovalchuk S; Annibali O; Rigacci L; Ferrari S; Gini G; Vigliotti ML; Mulè A; Flenghi L;

Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. in Hematological oncology / Hematol Oncol. 2018 Dec;36(5):757-764. doi: 10.1002/hon.2536. Epub 2018 Aug 16.

2018
ASL Biella
AOU Novara

Cavalli F; Gaidano G; Bertoni F; Bernasconi E; Nassi L; Kwee I; Dirnhofer S; Schmid P; Scherrer A; Staehelin C; Novak U; Battegay M; Hasse B; Darling K; Margiotta-Casaluci G; Conconi A; Zucca E;

PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization. in Hematological oncology / Hematol Oncol. 2015 Sep;33(3):125-32. doi: 10.1002/hon.2148. Epub 2014 May 29.

2015
AOU Novara

Rossi G; Skert C; Morello E; Almici C; Arcaini L; Basilico C; Cavalli L; Botto B; Castelli A; Pica G; Ripamonti F; Salvi F; Carella AM; Gaidano G; Levis A; Nosari A; Russo D; Vitolo U;

Richter syndrome: molecular insights and clinical perspectives. in Hematological oncology / Hematol Oncol. 2009 Mar;27(1):1-10. doi: 10.1002/hon.880.

2009
AOU Novara

Rossi D; Gaidano G;